Ensol Biosciences Inc. (XKON:140610)
South Korea · Delayed Price · Currency is KRW 9,450.00
-300.00 (-3.08%)
At close: Oct 15, 2026
Ensol Biosciences Market Cap
Ensol Biosciences has a market cap or net worth of 133.27 billion as of October 16, 2026. It is the 25,197th most valuable company in the world and the 1,062nd biggest in South Korea. Its market cap has decreased by 31.09% in one year.
Market Cap
133.27B
Enterprise Value
n/a
Revenue
537.46M
Global Rank
Country Rank
#1,062 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since September 10, 2018, Ensol Biosciences's market cap has increased from 106.21B to 133.27B, an increase of 25.48%. That is a compound annual growth rate of 2.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 135.86B | -22.63% |
| Dec 30, 2025 | 175.59B | -10.18% |
| Dec 30, 2024 | 195.49B | 264.72% |
| Dec 28, 2023 | 53.60B | -23.21% |
| Dec 29, 2022 | 69.80B | -47.06% |
| Dec 30, 2021 | 131.85B | 5.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 10, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kangstem Biotech | 181.99B |
| NIBEC | 166.88B |
| ISU Abxis | 156.78B |
| Bio Solution | 149.41B |
| Kanaph Therapeutics | 135.80B |
| TiumBio | 122.56B |
| ViGenCell | 113.16B |
| Y-Biologics | 105.88B |